ReviewPharmacogenomics2016

Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.

Claudia M Hattinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.